
Top ten essential value-based care fundamentals your practice cannot miss
Higher Part D deductibles, rising Medigap and Part B premiums and the end of $0-premium drug plans may lead patients to skip refills and visits early in 2027. Here’s who is most exposed, why lower utilization could mask 2028 costs and what to do before Dec. 7 and in January.
Medicare’s 2027 changes are likely to push many beneficiaries to skip follow-ups, abandon prescriptions or postpone referrals. To health plans and enablement companies, that may look like good news, but it’s not.
Click to read the article on The 2027 Medicare squeeze.




